NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ:SVRA) and certain officers.â?¯â?¯ The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 25-cv-05147, is […]
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ:FTNT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Tronox Holdings Plc ("Tronox" or the "Company") (NYSE:TROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP announces that a securities fraud class action lawsuit has been filed against Sina Corporation ("Sina" or the "Company") (formerly NASDAQ:SINA) and certain of its executive officers (collectively, "Defendants") on behalf of investors who sold Sina ordinary shares, including those that sold
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
Buck Sexton, Former CIA Officer, Reveals “Manhattan II” Inside the estimated $2.2 Trillion Artificial Superintelligence Initiative That Could Reshape America's Economy and Create Fortunes Across a New Technological Frontier GlobeNewswire November 01, 2025 Washington, D.C., Nov. 01, 2025 (GLOBE NEWSWIRE) — In a newly released interview, former CIA officer Buck Sexton unveiled what he calls
QMCO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Quantum Corporation Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action First Filed by the Firm – QMCO GlobeNewswire November 01, 2025 NEW YORK, Nov. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX GlobeNewswire November 01, 2025 NEW YORK, Nov. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX)
IMS Hash Launches New XRP Hash Power Platform, Leading a New Model for Ripple Asset Growth Empowering global investors with technological innovation, making it easier for crypto assets to grow from holding to appreciation. GlobeNewswire November 01, 2025 Chicago, Illinois, Nov. 01, 2025 (GLOBE NEWSWIRE) — IMS Hash, a leading global provider of crypto asset